相关实验视频

Updated: Jan 12, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

人工智能在肝癌干预疗法的进化中:导航瘤微环境

Zhe Xiu¹, Wenlong Zeng¹, Jianyang Guo¹

¹Department of Hepatobiliary Surgery, The Second Hospital of Longyan, 364000 Longyan, Fujian, China.

Frontiers in bioscience (Landmark edition)

|November 6, 2025

概括

人工智能 (AI) 通过分析瘤微环境 (TME) 来增强肝癌的干预疗法. 这种整合旨在提高精度,个性化治疗,并优化肝细胞癌 (HCC) 患者的治疗结果.

科学领域:

在瘤学瘤学.
医疗成像医学成像
人工智能的人工智能

背景情况:

肝细胞癌 (HCC) 是一个主要的全球健康问题.
瘤微环境 (TME) 显著影响HCC的进展和治疗耐药性.
干预疗法对于不可切除的肝癌至关重要.

研究的目的:

审查肝癌的现代干预疗法.
突出最小侵入性手术和人工智能集成方面的进展.
探索TME和AI在个性化HCC治疗中的作用.

主要方法:

对肝癌干预疗法的文献综述.
分析肝脏瘤微环境 (TME) 和其组成部分.
讨论人工智能 (AI) 在TME特征和治疗个性化中的应用.

主要成果:

人工智能集成提高了干预性肝癌治疗的精度和个性化.
了解TME复杂性是预测治疗反应的关键.
人工智能可以解读TME的复杂性,以指导患者的分类和治疗选择.

结论:

利用人工智能对TME进行分析,为改善肝癌管理提供了显著的潜力.
由人工智能和TME洞察得到的个性化干预策略可以提高患者的治疗结果.
对AI-TME相互作用的进一步研究对于推进HCC护理至关重要.

关键词:

人工智能的人工智能是人工智能.肝细胞癌是肝细胞癌.干预性治疗是一种干预性治疗.肝癌肝癌是一种肝癌.瘤微环境是一个微环境.

更多相关视频

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...